ACS Applied Materials & Interfaces,
Journal Year:
2016,
Volume and Issue:
8(33), P. 21107 - 21133
Published: June 29, 2016
Smart
drug
delivery
systems
(DDSs)
have
attracted
the
attention
of
many
scientists,
as
carriers
that
can
be
stimulated
by
changes
in
environmental
parameters
such
temperature,
pH,
light,
electromagnetic
fields,
mechanical
forces,
etc.
These
smart
nanocarriers
release
their
cargo
on
demand
when
target
is
reached
and
stimulus
applied.
Using
techniques
nanotechnology,
these
tailored
to
target-specific,
exhibit
delayed
or
controlled
drugs.
Temperature-responsive
are
one
most
important
groups
nanoparticles
(NPs)
been
investigated
during
past
decades.
Temperature
either
act
an
external
heat
applied
from
outside,
internal
pathological
lesions
a
naturally
elevated
termperature.
A
low
critical
solution
temperature
(LCST)
special
feature
some
polymeric
materials,
temperature-responsive
designed
based
this
feature.
In
review,
we
attempt
summarize
recent
efforts
prepare
innovative
discuss
novel
applications.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology,
Journal Year:
2016,
Volume and Issue:
9(1)
Published: June 16, 2016
Nanomedicine
is
a
relatively
new
field
that
rapidly
evolving.
Formulation
of
drugs
on
the
nanoscale
imparts
many
physical
and
biological
advantages.
Such
advantages
can
in
turn
translate
into
improved
therapeutic
efficacy
reduced
toxicity.
While
approximately
50
nanotherapeutics
have
already
entered
clinical
practice,
greater
number
are
undergoing
investigation
for
variety
indications.
This
review
aims
to
examine
all
nanoformulations
currently
their
outlook
ultimate
translation.
WIREs
Nanomed
Nanobiotechnol
2017,
9:e1416.
doi:
10.1002/wnan.1416
article
categorized
under:
Therapeutic
Approaches
Drug
Discovery
>
Emerging
Technologies
Expert Opinion on Drug Delivery,
Journal Year:
2016,
Volume and Issue:
13(11), P. 1609 - 1623
Published: May 24, 2016
Introduction:
One
of
the
biggest
impacts
that
nanotechnology
has
made
on
medicine
and
biology,
been
in
area
drug
delivery
systems
(DDSs).
Many
drugs
suffer
from
serious
problems
concerning
insolubility,
instability
biological
environments,
poor
uptake
into
cells
tissues,
sub-optimal
selectivity
for
targets
unwanted
side
effects.
Nanocarriers
can
be
designed
as
DDSs
to
overcome
many
these
drawbacks.
most
versatile
building
blocks
prepare
nanocarriers
is
ubiquitous,
readily
available
inexpensive
protein,
serum
albumin.Areas
covered:
This
review
covers
use
different
types
albumin
(human,
bovine,
rat,
chicken
egg)
nanoparticle
microparticle-based
structures
bind
drugs.
Various
methods
have
used
modify
structure.
A
range
targeting
ligands
attached
recognized
by
specific
cell
receptors
are
expressed
target
or
tissues.Expert
opinion:
The
particular
advantages
include
ready
availability,
ease
chemical
modification,
good
biocompatibility,
low
immunogenicity.
regulatory
approvals
received
several
albumin-based
therapeutic
agents
suggest
this
approach
will
continue
successfully
explored.